Placebo to Elagolix

DRUG2 trials

Sponsors

AbbVie

Conditions

Endometriosis

Phase 2

Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis

CompletedNCT00437658

AbbVieEndometriosis

Start: 2006-12-11End: 2008-11-24Updated: 2018-10-12

Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis

CompletedNCT00797225

AbbVieEndometriosis

Start: 2008-11-26End: 2010-02-24Updated: 2018-09-10

Related Papers

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study

Journal of Endometriosis and Pelvic Pain Disorders2015-04-0128 citations